Page 167 - Central Point News Today

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to te...

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to te...

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have long been accepted as a trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. The U.S. Food and Drug Administration is pushing drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. One group is planning a study to te...

Investment in healthier, locally produced school foods gave author Lola Milholland a chance to give back to the school and Japanese American community that gave so much to her

Cancer patients and doctors have ignited a movement to radically change how new cancer drugs are tested to make them more tolerable. Harsh side effects from powerful cancer drugs have

In a major shift, cancer patients and doctors are uniting to question the necessity of enduring harsh side effects caused by powerful drugs.

The U.S. Food and Drug Administration urging drugmakers to do a better job at finding the lowest effective dose

After advocacy from patients and doctors, the FDA is now pushing drugmakers to find the lowest effective dose of cancer drugs to reduce harsh side effects.

The Central Point Cemetery is the final resting place for over 1900 people. Before the City of Central Point took it over in 2021, the cemetery rarely received maintenance.

Through Project Optimus, the US Food and Drug Administration is encouraging drug developers to conduct more head-to-head dosing comparisons. | Health